首页> 美国卫生研究院文献>Diagnostics >Comparison of Sensitivity and Specificity of Biparametric versus Multiparametric Prostate MRI in the Detection of Prostate Cancer in 431 Men with Elevated Prostate-Specific Antigen Levels
【2h】

Comparison of Sensitivity and Specificity of Biparametric versus Multiparametric Prostate MRI in the Detection of Prostate Cancer in 431 Men with Elevated Prostate-Specific Antigen Levels

机译:与前列腺特异性抗原水平升高的431名男性前列腺癌的敏感性和敏感性和特异性比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

(1) Background: the study of dynamic contrast enhancement (DCE) has a limited role in the detection of prostate cancer (PCa), and there is a growing interest in performing unenhanced biparametric prostate-MRI (bpMRI) instead of the conventional multiparametric-MRI (mpMRI). In this study, we aimed to retrospectively compare the performance of the mpMRI, which includes DCE study, and the unenhanced bpMRI, composed of only T2-weighted imaging and diffusion-weighted imaging (DWI), in PCa detection in men with elevated prostate-specific-antigen (PSA) levels. (2) Methods: a 1.5 T MRI, with an endorectal-coil, was performed on 431 men (aged 61.5 ± 8.3 years) with a PSA ≥4.0 ng/mL. The bpMRI and mpMRI tests were independently assessed in separate sessions by two readers with 5 (R1) and 3 (R2) years of experience. The histopathology or ≥2 years follow-up served as a reference standard. The sensitivity and specificity were calculated with their 95% CI, and McNemar’s and Cohen’s κ statistics were used. (3) Results: in 195/431 (45%) of histopathologically proven PCa cases, 62/195 (32%) were high-grade PCa (GS ≥ 7b) and 133/195 (68%) were low-grade PCa (GS ≤ 7a). The PCa could be excluded by histopathology in 58/431 (14%) and by follow-up in 178/431 (41%) of patients. For bpMRI, the sensitivity was 164/195 (84%, 95% CI: 79–89%) for R1 and 156/195 (80%, 95% CI: 74–86%) for R2; while specificity was 182/236 (77%, 95% CI: 72–82%) for R1 and 175/236 (74%, 95% CI: 68–80%) for R2. For mpMRI, sensitivity was 168/195 (86%, 95% CI: 81–91%) for R1 and 160/195 (82%, 95% CI: 77–87%) for R2; while specificity was 184/236 (78%, 95% CI: 73–83%) for R1 and 177/236 (75%, 95% CI: 69–81%) for R2. Interobserver agreement was substantial for both bpMRI (κ = 0.802) and mpMRI (κ = 0.787). (4) Conclusions: the diagnostic performance of bpMRI and mpMRI were similar, and no high-grade PCa was missed with bpMRI.
机译:(1)背景:动态对比增强(DCE)的研究在检测前列腺癌(PCA)中具有有限的作用,并且在执行未加入的双轴术前列腺-MRI(BPMRI)而不是传统的多级 - MRI(MPMRI)。在这项研究中,我们旨在回顾性地比较MPMRI的性能,该MPMRI包括DCE研究,以及由T2加权成像和扩散加权成像(DWI)组成的未加入BPMRI,在升高前列腺的男性中的PCA检测中 - 特异性抗原(PSA)水平。 (2)方法:一个1.5T的MRI,用直肠内线圈,于431名男性(年龄61.5±8.3岁)具有PSA≥4.0毫微克/毫升进行。 BPMRI和MPMRI测试在两个读者的单独会话中独立评估,其中两个读者有5(R1)和3(R2)多年的经验。组织病理学或≥2年随访曾作为参考标准。用95%CI计算敏感性和特异性,使用McNemar和Cohen的κ统计数据。 (3)结果:195/431(45%)组织病理学证明的PCA病例,62/195(32%)是高档PCA(GS≥7b)和133/195(68%)是低级PCA( gs≤7a)。 PCA可以在58/431(14%)和178/431(41%)的患者中的后续后被排除。对于BPMRI,敏感性为R1和156/195的敏感性为164/195(84%,95%CI:79-89%)(80%,95%CI:74-86%),用于R2;对于R1和175/236的特异性为182/236(77%,95%:72-82%)(74%,95%CI:68-80%)的R2。对于MPMRI,敏感性为R1和160/195(82%,95%CI:77-87%)的R2为168/195(86%,95%CI:81-91%);虽然特异性为R1和177/236的184/236(78%,95%CI:73-83%)(75%,95%CI:69-81%)的R2。 Interobserver协议对于BPMRI(κ= 0.802)和MPMRI(κ= 0.787)很重要。 (4)结论:BPMRI和MPMRI的诊断性能相似,没有BPMRI没有高档PCA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号